Advertisement
Screener

GUARDANT HEALTH, INC. (GH) Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer

3.2 / 5 stars · 50/77 Roast Me

GUARDANT HEALTH, INC. Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer

GUARDANT HEALTH, INC. (GH) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer of $161.62 million as of 2023-09-30, per its 10-Q filed 2023-11-06.

Discontinued › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger · last filed 2024-02-22

  • 2023-09-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $161.62M.
  • 2023-06-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $389.22M.
  • 2023-03-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $590.85M.
  • 2022-12-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $685.75M.
Period endDebt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer
2023-09-30$161.62M
10-Q · filed 2023-11-06
2023-06-30$389.22M
10-Q · filed 2023-08-03
2023-03-31$590.85M
10-Q · filed 2023-05-09
2022-12-31$685.75M
10-K · filed 2024-02-22
2022-09-30$108.54M
10-Q · filed 2022-11-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
LABCORP HOLDINGS INC. (LH)United States$25.060B22.60
QUEST DIAGNOSTICS INC (DGX)United States$26.096B22.09
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30